Senseonics Holdings (SENS) Consolidated Net Income (2015 - 2026)

Senseonics Holdings' (SENS) quarterly Consolidated Net Income came in at -$41.0 million in Q1 2026, down 91.26% year-on-year from -$468.7 million in Q1 2025, and down 96.78% on a QoQ basis from -$20.8 million in Q4 2025.

Senseonics Holdings (SENS) Consolidated Net Income (2015 - 2026) Analysis & Trends

Senseonics Holdings (SENS) has 12 years of Consolidated Net Income data on file, last reported at -$41.0 million in Q1 2026.

  • On a quarterly basis, Consolidated Net Income fell 91.26% year-over-year to -$41.0 million in Q1 2026; TTM through Mar 2026 was -$110.0 million, a 29.12% decrease from a year earlier, with the FY2025 full-year figure at -$72.0 million, up 8.56% from the prior year.
  • Consolidated Net Income for Q1 2026 stood at -$41.0 million, down from -$20.8 million in the prior quarter.
  • Over the last five years, Consolidated Net Income for SENS reached as high as -$10.7 million in Q4 2022 and fell as low as -$41.0 million in Q1 2026.
  • Historically, Consolidated Net Income has averaged -$22.2 million across 5 years, with a median of -$21.4 million in 2025.
  • Across the five-year window, Consolidated Net Income surged 62.14% in 2022 and slumped 91.26% in 2026, its largest moves.
  • Year by year, Consolidated Net Income stood at -$10.7 million in 2022, then slumped by 61.89% to -$17.2 million in 2023, then soared by 32.27% to -$11.7 million in 2024, then tumbled by 78.26% to -$20.8 million in 2025, then tumbled by 96.78% to -$41.0 million in 2026.
  • Per Business Quant data, the three most recent Consolidated Net Income figures were -$41.0 million in Q1 2026, -$20.8 million in Q4 2025, and -$26.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Abbott Laboratories 183.85 Bn 176.55 Bn 6.27 Bn 1.08 Bn
2 Stryker 128.90 Bn 126.02 Bn 3.81 Bn 745.00 Mn
3 Medtronic 108.55 Bn 99.33 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 68.56 Bn 67.10 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 48.24 Bn 44.57 Bn 1.29 Bn -
6 Dexcom 28.40 Bn 27.28 Bn 750.30 Mn 199.50 Mn
7 GE HealthCare Technologies 28.15 Bn 25.87 Bn 1.98 Bn 411.00 Mn
8 Smith & Nephew 26.89 Bn 26.31 Bn - -
9 Koninklijke Philips 24.75 Bn 21.63 Bn 2.07 Bn 273.95 Mn
10 Senseonics Holdings 230.03 Mn 165.71 Mn 6.94 Mn -40.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -40.96 Mn
Dec 31, 2025 -20.82 Mn
Sep 30, 2025 -26.50 Mn
Jun 30, 2025 -21.72 Mn
Mar 31, 2025 -21.42 Mn
Dec 31, 2024 -11.68 Mn
Sep 30, 2024 -30.90 Mn
Jun 30, 2024 -21.19 Mn
Mar 31, 2024 -18.90 Mn
Dec 31, 2023 -17.24 Mn
Sep 30, 2023 -27.59 Mn
Jun 30, 2023 -22.01 Mn
Mar 31, 2023 -23.25 Mn
Dec 31, 2022 -10.65 Mn
Sep 30, 2022 -21.83 Mn
Jun 30, 2022 -21.31 Mn
Mar 31, 2022 -19.56 Mn
Dec 31, 2021 -28.14 Mn
Sep 30, 2021 -19.79 Mn
Jun 30, 2021 -19.68 Mn